openPR Logo
Press release

Herpes Marker Testing Market Explores New Growth Opportunities By 2023

05-05-2017 04:03 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Herpes Marker Testing Market Explores New Growth Opportunities

Herpes virus is a ubiquitous pathogen whose primary infections are usually asymptomatic. There are two types of Herpes Simplex virus (HSV): HSV-1 is known to cause orofacial disease such as cold sores; while HSV-2 causes genital infections. Over 80% of the herpes infections are asymptomatic; symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. Period of latency and mode of reactivation of HSV is yet unclear.

This Report Gives Readers a Comprehensive Overview of Herpes Marker Testing Market: http://www.transparencymarketresearch.com/herpes-marker-testing-market.html

Herpes Simplex is a highly contagious virus which is passes through direct contact with infected patients. The virus is transferred through body fluids such as saliva, blood and semen. Some studies have also shown that the virus can be transferred through breast milk. HSV infection is also common in patients with compromised immune system. Thus transplant patients and human immunodeficiency virus (HIV) positive patients are at higher risk of acquiring HSV infections. Since majority of HSV infections are asymptomatic, physicians are dependent on diagnostic tests for accurate diagnosis and treatment. Currently, there are four types of tests available for HSV biomarker testing; these include cell culture tests, antigen tests, antibody tests, and polymerase chain reaction (PCR) tests. In cell culture tests, specimens from the skin lesions or blisters are taken to develop viral cultures. Although the test is more accurate, it is time consuming and may give false negative results if lesions are in process of healing. Antigen and antibody tests are enzyme linked Immunosorbent assay (ELISA) based tests and are the most widely used tests globally. Blood samples are usually tested for HSV antigens and antibodies. These rapid tests provide quick and accurate results, which helps in further diagnosis and treatments. PCR tests have been the most accurate tests used for HSV diagnosis. The test can also differentiate between HSV-1 and HSV-2 viral load.

According to prevalence statistics published by Centers for Disease Control and Prevention (CDC), HSV-2 prevalence was found to be over 16% in the U.S. citizens and mainly affected African-America female population. Public Health Agency of Canada mentions that prevalence of HSV-1 infection is greater than HSV-2 infections is most of the geographical regions. The data also shows that HSV-1 seroprevalence in adults in over 70% in developed countries, while almost 100% in developing and underdeveloped countries. Various publications also show that prevalence of HIV is higher in low and middle income countries. Thus it is expected that the prevalence of herpes simplex virus would remain high in these countries. Due to under developed economic conditions, cost effective diagnosed tests are in high demand. In spite of these conditions, North America and Europe lead the market owing to higher seroprevalence, and large number of transplant and HIV patients.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Herpes Marker Testing Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5510

In 2014, U.S. FDA approved Quest Diagnostics, Inc’s HSV diagnostic test Simplexa HSV 1 and 2 direct molecular test on the 3M Integrated Cycler. The Simplexa test is the first molecular test that has been approved by the U.S. FDA, that enables qualitative detection as well as differentiation of HSV-1 and HSV-2 in cerebrospinal fluid (CSF). Other diagnostic tests in the market include Capita IgG test by Trinity Biotech, IsoAmp HSV Assay by Biohelix and HerpeSelect by Focus Diagnostics. Some of the key players in the global herpes marker testing market include DiaSorin, Roche, Enzo Life Sciences and Thermo Fisher Scientific.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Herpes Marker Testing Market Explores New Growth Opportunities By 2023 here

News-ID: 525685 • Views: 242

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for HSV

Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, …
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,
Global Expanded Thermoplastic Polyurethane Market Growth during the Forecast Per …
Since the expanded thermoplastic polyurethanes are in the introduction phase in the Expanded Thermoplastic Polyurethane Market, the demand for expanded thermoplastic polyurethanes is expected to rise in the coming years. Manufacturers are focused on development of expanded thermoplastic polyurethanes for newer application areas. Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2519 Properties offered by expanded thermoplastic polyurethane are a combination of the properties of thermoplastic polyurethane and foam. Expanded thermoplastic polyurethane is a highly
Global Expanded Thermoplastic Polyurethane Market Exhibits Higher Growth Prospec …
Since the expanded thermoplastic polyurethanes are in the introduction phase in the Expanded Thermoplastic Polyurethane Market, the demand for expanded thermoplastic polyurethanes is expected to rise in the coming years. Manufacturers are focused on development of expanded thermoplastic polyurethanes for newer application areas. Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2519 Properties offered by expanded thermoplastic polyurethane are a combination of the properties of thermoplastic polyurethane and foam. Expanded thermoplastic polyurethane is a highly
Expanded Thermoplastic Polyurethane Market Expected to Deliver Dynamic Progressi …
Expanded Thermoplastic Polyurethane Market Participants Some of the participants involved in this market are listed below: BASF SE The Lubrizol Corporation Huntsman Corporation The Dow Chemical Company Sunko Ink Co., Ltd HSV Moulded Foams Group Plymouth Foam IMG Plastec LLC The Expanded Thermoplastic Polyurethane market research report presents a comprehensive assessment of the Expanded Thermoplastic Polyurethane market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated Expanded Thermoplastic Polyurethane market data. It also contains projections using a
Global Expanded Thermoplastic Polyurethane Market Expected to Deliver Dynamic Pr …
Since the expanded thermoplastic polyurethanes are in the introduction phase in the Expanded Thermoplastic Polyurethane Market, the demand for expanded thermoplastic polyurethanes is expected to rise in the coming years. Manufacturers are focused on development of expanded thermoplastic polyurethanes for newer application areas. Request a Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=2519 Properties offered by expanded thermoplastic polyurethane are a combination of the properties of thermoplastic polyurethane and foam. Expanded thermoplastic polyurethane is a highly
Herpes Marker Testing Market : HSV-1/HSV-2 segment to rise with growth rate of 6 …
Leading players operating in the global herpes marker testing market covered in the report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc. and Teco Diagnostics. According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global